CAS: 59338-93-1 - Alizapride
Fórmula:C16H22ClN5O2
InChI:InChI=1S/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20)
Clave InChI:InChIKey=KSEYRUGYKHXGFW-UHFFFAOYSA-N
SMILES:O=C(NCC1N(CC=C)CCC1)C2=CC=3N=NNC3C=C2OC
- Sinónimos:
- 1H-Benzotriazole-5-carboxamide, 6-methoxy-N-[[1-(2-propen-1-yl)-2-pyrrolidinyl]methyl]-
- 1H-Benzotriazole-5-carboxamide, 6-methoxy-N-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]-
- 6-Methoxy-N-[(1-Prop-2-Enylpyrrolidin-2-Yl)Methyl]-2H-Benzotriazole-5-Carboxamide Hydrochloride
- 6-Methoxy-N-[[1-(2-propen-1-yl)-2-pyrrolidinyl]methyl]-1H-benzotriazole-5-carboxamide
- 6-methoxy-N-[(1-prop-2-en-1-ylpyrrolidin-2-yl)methyl]-2H-benzotriazole-5-carboxamide hydrochloride
- 6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-benzotriazole-5-carboxamide
- Alizaprid
- Alizaprida
- Alizapride Hydrochloride
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Alizapride REF: 7W-GP4425CAS: 59338-93-1 | - - - | A consultar | Vie 29 Nov 24 | |
Alizapride REF: TM-T60813CAS: 59338-93-1 | - - - | 1.437,00 €~2.364,00 € | Jue 05 Dic 24 | |
Alizapride REF: 3D-JCA33893CAS: 59338-93-1 | Min. 95% | A consultar | Jue 09 Ene 25 |
Ref: 7W-GP4425
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 29 de Noviembre de 2024
Alizapride
CAS:59338-93-1
Alizapride is an antagonist of dopamine receptor. Alizapride can be used in human digestive disorders …
Fórmula:
C16H21N5O2
Forma y color:
Liquid
Peso molecular:
315.37
Ref: TM-T60813
25mg | 1.437,00 € | ||
50mg | 1.872,00 € | ||
100mg | 2.364,00 € |
Entrega estimada en Estados Unidos, el Jueves 5 de Diciembre de 2024
Alizapride
CAS:59338-93-1
Alizapride is a pharmaceutical preparation that is used for the treatment of infectious diseases and …
Fórmula:
C16H22ClN5O2
Pureza:
Min. 95%
Peso molecular:
351.8 g/mol
Ref: 3D-JCA33893
5g | A consultar | ||
10g | A consultar |
Entrega estimada en Estados Unidos, el Jueves 9 de Enero de 2025